Changes in Left Heart Geometry, Function, and Blood Serum Biomarkers in Patients with Obstructive Sleep Apnea after Treatment with Continuous Positive Airway Pressure

Background: Cardiovascular remodeling is essential in patients with obstructive sleep apnea (OSA), and continuous positive airway pressure (CPAP) therapy could improve these processes. Two-dimensional (2D) speckle-tracking (ST) echocardiography is a useful method for subclinical biventricular dysfun...

Full description

Saved in:
Bibliographic Details
Published in:Medicina (Kaunas, Lithuania) Vol. 58; no. 11; p. 1511
Main Authors: Kondratavičienė, Laima, Tamulėnaitė, Eglė, Vasylė, Eglė, Januškevičius, Andrius, Ereminienė, Eglė, Malakauskas, Kęstutis, Žemaitis, Marius, Miliauskas, Skaidrius
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 24.10.2022
MDPI
Subjects:
ISSN:1648-9144, 1010-660X, 1648-9144
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background: Cardiovascular remodeling is essential in patients with obstructive sleep apnea (OSA), and continuous positive airway pressure (CPAP) therapy could improve these processes. Two-dimensional (2D) speckle-tracking (ST) echocardiography is a useful method for subclinical biventricular dysfunction diagnosis and thus might help as an earlier treatment for OSA patients. It is still not clear which blood serum biomarkers could be used to assess CPAP treatment efficacy. Objectives: To evaluate left heart geometry, function, deformation parameters, and blood serum biomarker (galectin-3, sST2, endothelin-1) levels in patients with OSA, as well as to assess changes after short-term CPAP treatment. Materials and Methods: Thirty-four patients diagnosed with moderate or severe OSA, as well as thirteen patients as a control group, were included in the study. All the subjects were obese (body mass index (BMI) > 30 kg/m2). Transthoracic 2D ST echocardiography was performed before and after 3 months of treatment with CPAP; for the control group, at baseline only. Peripheral blood samples for the testing of biomarkers were collected at the time of study enrolment before the initiation of CPAP therapy and after 3 months of CPAP treatment (blood samples were taken just for OSA group patients). Results: The left ventricle (LV) end-diastolic diameter and volume, as well as LV ejection fraction (EF), did not differ between groups, but an increased LV end-systolic volume and a reduced LV global longitudinal strain (GLS) were found in the OSA group patients (p = 0.015 and p = 0.035, respectively). Indexed by height, higher LV MMi in OSA patients (p = 0.007) and a higher prevalence of LV diastolic dysfunction (p = 0.023) were found in this group of patients. Although left atrium (LA) volume did not differ between groups, OSA group patients had significantly lower LA reservoir strain (p < 0.001). Conventional RV longitudinal and global function parameters (S′, fractional area change (FAC)) did not differ between groups; however, RV GLS was reduced in OSA patients (p = 0.026). OSA patients had a significantly higher right atrium (RA) diameter and mean pulmonary artery pressure (PAP) (p < 0.05). Galectin-3 and sST2 concentrations significantly decreased after 3 months of CPAP treatment. Conclusions: OSA is associated with the left heart remodeling process—increased LV myocardial mass index, LV diastolic dysfunction, reduced LV and RV longitudinal strain, and reduced LA reservoir function. A short-term, 3-months CPAP treatment improves LV global longitudinal strain and LA reservoir function and positively affects blood serum biomarkers. This new indexing system for LV myocardial mass by height helps to identify myocardial structural changes in obese patients with OSA.
AbstractList Background: Cardiovascular remodeling is essential in patients with obstructive sleep apnea (OSA), and continuous positive airway pressure (CPAP) therapy could improve these processes. Two-dimensional (2D) speckle-tracking (ST) echocardiography is a useful method for subclinical biventricular dysfunction diagnosis and thus might help as an earlier treatment for OSA patients. It is still not clear which blood serum biomarkers could be used to assess CPAP treatment efficacy. Objectives: To evaluate left heart geometry, function, deformation parameters, and blood serum biomarker (galectin-3, sST2, endothelin-1) levels in patients with OSA, as well as to assess changes after short-term CPAP treatment. Materials and Methods: Thirty-four patients diagnosed with moderate or severe OSA, as well as thirteen patients as a control group, were included in the study. All the subjects were obese (body mass index (BMI) > 30 kg/m2). Transthoracic 2D ST echocardiography was performed before and after 3 months of treatment with CPAP; for the control group, at baseline only. Peripheral blood samples for the testing of biomarkers were collected at the time of study enrolment before the initiation of CPAP therapy and after 3 months of CPAP treatment (blood samples were taken just for OSA group patients). Results: The left ventricle (LV) end-diastolic diameter and volume, as well as LV ejection fraction (EF), did not differ between groups, but an increased LV end-systolic volume and a reduced LV global longitudinal strain (GLS) were found in the OSA group patients (p = 0.015 and p = 0.035, respectively). Indexed by height, higher LV MMi in OSA patients (p = 0.007) and a higher prevalence of LV diastolic dysfunction (p = 0.023) were found in this group of patients. Although left atrium (LA) volume did not differ between groups, OSA group patients had significantly lower LA reservoir strain (p < 0.001). Conventional RV longitudinal and global function parameters (S′, fractional area change (FAC)) did not differ between groups; however, RV GLS was reduced in OSA patients (p = 0.026). OSA patients had a significantly higher right atrium (RA) diameter and mean pulmonary artery pressure (PAP) (p < 0.05). Galectin-3 and sST2 concentrations significantly decreased after 3 months of CPAP treatment. Conclusions: OSA is associated with the left heart remodeling process—increased LV myocardial mass index, LV diastolic dysfunction, reduced LV and RV longitudinal strain, and reduced LA reservoir function. A short-term, 3-months CPAP treatment improves LV global longitudinal strain and LA reservoir function and positively affects blood serum biomarkers. This new indexing system for LV myocardial mass by height helps to identify myocardial structural changes in obese patients with OSA.
Background: Cardiovascular remodeling is essential in patients with obstructive sleep apnea (OSA), and continuous positive airway pressure (CPAP) therapy could improve these processes. Two-dimensional (2D) speckle-tracking (ST) echocardiography is a useful method for subclinical biventricular dysfunction diagnosis and thus might help as an earlier treatment for OSA patients. It is still not clear which blood serum biomarkers could be used to assess CPAP treatment efficacy. Objectives: To evaluate left heart geometry, function, deformation parameters, and blood serum biomarker (galectin-3, sST2, endothelin-1) levels in patients with OSA, as well as to assess changes after short-term CPAP treatment. Materials and Methods: Thirty-four patients diagnosed with moderate or severe OSA, as well as thirteen patients as a control group, were included in the study. All the subjects were obese (body mass index (BMI) > 30 kg/m2). Transthoracic 2D ST echocardiography was performed before and after 3 months of treatment with CPAP; for the control group, at baseline only. Peripheral blood samples for the testing of biomarkers were collected at the time of study enrolment before the initiation of CPAP therapy and after 3 months of CPAP treatment (blood samples were taken just for OSA group patients). Results: The left ventricle (LV) end-diastolic diameter and volume, as well as LV ejection fraction (EF), did not differ between groups, but an increased LV end-systolic volume and a reduced LV global longitudinal strain (GLS) were found in the OSA group patients (p = 0.015 and p = 0.035, respectively). Indexed by height, higher LV MMi in OSA patients (p = 0.007) and a higher prevalence of LV diastolic dysfunction (p = 0.023) were found in this group of patients. Although left atrium (LA) volume did not differ between groups, OSA group patients had significantly lower LA reservoir strain (p < 0.001). Conventional RV longitudinal and global function parameters (S′, fractional area change (FAC)) did not differ between groups; however, RV GLS was reduced in OSA patients (p = 0.026). OSA patients had a significantly higher right atrium (RA) diameter and mean pulmonary artery pressure (PAP) (p < 0.05). Galectin-3 and sST2 concentrations significantly decreased after 3 months of CPAP treatment. Conclusions: OSA is associated with the left heart remodeling process—increased LV myocardial mass index, LV diastolic dysfunction, reduced LV and RV longitudinal strain, and reduced LA reservoir function. A short-term, 3-months CPAP treatment improves LV global longitudinal strain and LA reservoir function and positively affects blood serum biomarkers. This new indexing system for LV myocardial mass by height helps to identify myocardial structural changes in obese patients with OSA.Background: Cardiovascular remodeling is essential in patients with obstructive sleep apnea (OSA), and continuous positive airway pressure (CPAP) therapy could improve these processes. Two-dimensional (2D) speckle-tracking (ST) echocardiography is a useful method for subclinical biventricular dysfunction diagnosis and thus might help as an earlier treatment for OSA patients. It is still not clear which blood serum biomarkers could be used to assess CPAP treatment efficacy. Objectives: To evaluate left heart geometry, function, deformation parameters, and blood serum biomarker (galectin-3, sST2, endothelin-1) levels in patients with OSA, as well as to assess changes after short-term CPAP treatment. Materials and Methods: Thirty-four patients diagnosed with moderate or severe OSA, as well as thirteen patients as a control group, were included in the study. All the subjects were obese (body mass index (BMI) > 30 kg/m2). Transthoracic 2D ST echocardiography was performed before and after 3 months of treatment with CPAP; for the control group, at baseline only. Peripheral blood samples for the testing of biomarkers were collected at the time of study enrolment before the initiation of CPAP therapy and after 3 months of CPAP treatment (blood samples were taken just for OSA group patients). Results: The left ventricle (LV) end-diastolic diameter and volume, as well as LV ejection fraction (EF), did not differ between groups, but an increased LV end-systolic volume and a reduced LV global longitudinal strain (GLS) were found in the OSA group patients (p = 0.015 and p = 0.035, respectively). Indexed by height, higher LV MMi in OSA patients (p = 0.007) and a higher prevalence of LV diastolic dysfunction (p = 0.023) were found in this group of patients. Although left atrium (LA) volume did not differ between groups, OSA group patients had significantly lower LA reservoir strain (p < 0.001). Conventional RV longitudinal and global function parameters (S′, fractional area change (FAC)) did not differ between groups; however, RV GLS was reduced in OSA patients (p = 0.026). OSA patients had a significantly higher right atrium (RA) diameter and mean pulmonary artery pressure (PAP) (p < 0.05). Galectin-3 and sST2 concentrations significantly decreased after 3 months of CPAP treatment. Conclusions: OSA is associated with the left heart remodeling process—increased LV myocardial mass index, LV diastolic dysfunction, reduced LV and RV longitudinal strain, and reduced LA reservoir function. A short-term, 3-months CPAP treatment improves LV global longitudinal strain and LA reservoir function and positively affects blood serum biomarkers. This new indexing system for LV myocardial mass by height helps to identify myocardial structural changes in obese patients with OSA.
Background: Cardiovascular remodeling is essential in patients with obstructive sleep apnea (OSA), and continuous positive airway pressure (CPAP) therapy could improve these processes. Two-dimensional (2D) speckle-tracking (ST) echocardiography is a useful method for subclinical biventricular dysfunction diagnosis and thus might help as an earlier treatment for OSA patients. It is still not clear which blood serum biomarkers could be used to assess CPAP treatment efficacy. Objectives: To evaluate left heart geometry, function, deformation parameters, and blood serum biomarker (galectin-3, sST2, endothelin-1) levels in patients with OSA, as well as to assess changes after short-term CPAP treatment. Materials and Methods: Thirty-four patients diagnosed with moderate or severe OSA, as well as thirteen patients as a control group, were included in the study. All the subjects were obese (body mass index (BMI) > 30 kg/m[sup.2] ). Transthoracic 2D ST echocardiography was performed before and after 3 months of treatment with CPAP; for the control group, at baseline only. Peripheral blood samples for the testing of biomarkers were collected at the time of study enrolment before the initiation of CPAP therapy and after 3 months of CPAP treatment (blood samples were taken just for OSA group patients). Results: The left ventricle (LV) end-diastolic diameter and volume, as well as LV ejection fraction (EF), did not differ between groups, but an increased LV end-systolic volume and a reduced LV global longitudinal strain (GLS) were found in the OSA group patients (p = 0.015 and p = 0.035, respectively). Indexed by height, higher LV MMi in OSA patients (p = 0.007) and a higher prevalence of LV diastolic dysfunction (p = 0.023) were found in this group of patients. Although left atrium (LA) volume did not differ between groups, OSA group patients had significantly lower LA reservoir strain (p < 0.001). Conventional RV longitudinal and global function parameters (S′, fractional area change (FAC)) did not differ between groups; however, RV GLS was reduced in OSA patients (p = 0.026). OSA patients had a significantly higher right atrium (RA) diameter and mean pulmonary artery pressure (PAP) (p < 0.05). Galectin-3 and sST2 concentrations significantly decreased after 3 months of CPAP treatment. Conclusions: OSA is associated with the left heart remodeling process—increased LV myocardial mass index, LV diastolic dysfunction, reduced LV and RV longitudinal strain, and reduced LA reservoir function. A short-term, 3-months CPAP treatment improves LV global longitudinal strain and LA reservoir function and positively affects blood serum biomarkers. This new indexing system for LV myocardial mass by height helps to identify myocardial structural changes in obese patients with OSA.
Audience Academic
Author Kondratavičienė, Laima
Malakauskas, Kęstutis
Vasylė, Eglė
Januškevičius, Andrius
Ereminienė, Eglė
Tamulėnaitė, Eglė
Žemaitis, Marius
Miliauskas, Skaidrius
AuthorAffiliation 3 Laboratory of Pulmonology, Department of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania
2 Department of Cardiology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania
1 Department of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania
AuthorAffiliation_xml – name: 3 Laboratory of Pulmonology, Department of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania
– name: 1 Department of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania
– name: 2 Department of Cardiology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania
Author_xml – sequence: 1
  givenname: Laima
  orcidid: 0000-0001-6384-9392
  surname: Kondratavičienė
  fullname: Kondratavičienė, Laima
– sequence: 2
  givenname: Eglė
  surname: Tamulėnaitė
  fullname: Tamulėnaitė, Eglė
– sequence: 3
  givenname: Eglė
  surname: Vasylė
  fullname: Vasylė, Eglė
– sequence: 4
  givenname: Andrius
  surname: Januškevičius
  fullname: Januškevičius, Andrius
– sequence: 5
  givenname: Eglė
  surname: Ereminienė
  fullname: Ereminienė, Eglė
– sequence: 6
  givenname: Kęstutis
  surname: Malakauskas
  fullname: Malakauskas, Kęstutis
– sequence: 7
  givenname: Marius
  surname: Žemaitis
  fullname: Žemaitis, Marius
– sequence: 8
  givenname: Skaidrius
  orcidid: 0009-0002-6130-0712
  surname: Miliauskas
  fullname: Miliauskas, Skaidrius
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36363468$$D View this record in MEDLINE/PubMed
BookMark eNp1kktP3DAUhaOqVXm0-64qS910wVA7sTP2ptIwKg8JCSTo2vLYN4NpYk9tB8Qf6u_sHQYQoDZeJLK_c3LP9d2p3oYYoKo-MbrfNIp-G8B564MRkjEmGHtTbbOWy4linL999r1V7eR8TWlTi2n9vtpqWly8ldvVn_mVCUvIxAdyCl0hx2BSIUcQByjpbo8cjsEWH8MeMcGRgz5GRy4gjQM58HEw6Reke_G5KR5CyeTWlytytsgljSi8AXLRA6zIbBXAENMVSOQygSkD0ht4HkPxYYxjJucx-3vRzKdbc0fOE-Q8JvhQvetMn-Hjw3u3-nn443J-PDk9OzqZz04nVohpmYhFzaiTxtS248AUPvWikeCYExSUU52gAsBwbIRqFVBhZdcqbqTq2oa6Zrc62fi6aK71KnlMeKej8fp-I6alxvZ424OmxgrOasUtc9xJrpgBKh1vsQBWNwa9vm-8VuMCL8pi3mT6F6YvT4K_0st4o7EyqThDg68PBin-HiEXPfhsoe9NAGyWrqeNkK1sOEf0yyv0Oo4pYKvWFG9Fs67piVoaDOBDF_G_dm2qZ1POpZqKmiK1_w8Kl4PBWxzAzuP-C8Hn50GfEj5OGQLtBrAp5pyg09YXs54qdPa9ZlSvx1m_HmcU0lfCR-__Sv4CYsz6bw
CitedBy_id crossref_primary_10_1097_MD_0000000000033549
crossref_primary_10_1016_j_ijcrp_2025_200455
crossref_primary_10_1007_s11325_023_02842_z
crossref_primary_10_3390_life14070906
crossref_primary_10_1111_echo_70041
crossref_primary_10_3390_medicina59020326
crossref_primary_10_3390_jcm12113785
Cites_doi 10.1161/CIRCULATIONAHA.104.501841
10.3390/medicina58030350
10.1155/2014/930535
10.1164/rccm.201908-1593LE
10.5603/KP.a2016.0185
10.1161/JAHA.119.014609
10.1371/journal.pone.0062298
10.1155/2020/2587530
10.1177/1753466619880076
10.1378/chest.11-0615
10.1016/j.ijcha.2016.05.011
10.3343/alm.2018.38.4.306
10.1007/s00059-019-04850-w
10.1097/01.hjh.0000570772.89851.13
10.1016/j.echo.2014.10.003
10.1016/j.sleep.2021.03.039
10.21037/apm-20-1125
10.1016/j.ahj.2010.06.033
10.1378/chest.11-2322
10.1016/j.chest.2021.12.669
10.1016/j.acvd.2016.02.011
10.1016/j.exer.2010.11.009
10.1007/s00405-018-5225-8
10.3390/biom11081167
10.1111/jch.14488
10.1007/s11325-021-02382-4
10.1001/jamacardio.2016.0962
10.1016/j.echo.2016.01.011
10.1016/j.echo.2019.03.020
10.1093/ejechocard/jep215
10.1016/j.hfc.2019.08.009
10.1056/NEJMoa043104
10.1378/chest.12-2114
10.1183/16000617.0077-2015
10.1111/echo.13225
10.1080/AC.69.2.3017299
10.5551/jat.RV17009
10.1016/j.immuni.2005.09.015
10.1164/rccm.2109080
10.1056/NEJMoa1606599
10.1007/s11325-015-1260-5
10.1016/j.cca.2016.06.046
10.1161/01.CIR.0000061757.12581.15
10.1093/eurjcn/zvab060.126
10.1093/ehjci/jey042
10.1016/j.ccm.2006.12.001
10.1136/jcp.48.6.519
10.1016/j.sleep.2007.06.018
10.1007/s11325-019-01788-5
10.1038/s41598-019-49511-4
10.1155/2017/1587865
ContentType Journal Article
Copyright COPYRIGHT 2022 MDPI AG
2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: COPYRIGHT 2022 MDPI AG
– notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.3390/medicina58111511
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
ProQuest Health & Medical Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef

Publicly Available Content Database
MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1648-9144
ExternalDocumentID oai_doaj_org_article_0ac541294c1d4d8491ae08d460d8123a
PMC9698941
A744897520
36363468
10_3390_medicina58111511
Genre Journal Article
GeographicLocations Lithuania
GeographicLocations_xml – name: Lithuania
GroupedDBID 0R~
29M
2WC
4.4
457
53G
5GY
5VS
7X7
8FI
8FJ
AADQD
AAEDT
AAFWJ
AAIKJ
AAYXX
ABMAC
ABUWG
ACGFS
ADBBV
ADEZE
AFFHD
AFKRA
AFPKN
AFZYC
AGHFR
AHDRD
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
EMOBN
F5P
FDB
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
IHR
ITC
KQ8
MODMG
O9-
OK1
OVT
PGMZT
PHGZM
PHGZT
PIMPY
RPM
UKHRP
XSB
AACTN
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c557t-5b210d8aa2cf4e199992b38ed1d50e9d9f505eea4325969e05c8f694a89f630d3
IEDL.DBID BENPR
ISICitedReferencesCount 7
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000881113900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1648-9144
1010-660X
IngestDate Tue Oct 14 18:20:09 EDT 2025
Tue Nov 04 02:08:19 EST 2025
Fri Sep 05 13:10:11 EDT 2025
Tue Oct 07 07:12:40 EDT 2025
Tue Nov 11 11:13:45 EST 2025
Tue Nov 04 18:37:48 EST 2025
Thu Apr 03 07:08:42 EDT 2025
Tue Nov 18 22:15:35 EST 2025
Sat Nov 29 07:13:13 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords obstructive sleep apnea
two-dimensional speckle-tracking echocardiography
sST2
endothelin-1
continuous positive airway pressure
galectin-3
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c557t-5b210d8aa2cf4e199992b38ed1d50e9d9f505eea4325969e05c8f694a89f630d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0009-0002-6130-0712
0000-0001-6384-9392
OpenAccessLink https://www.proquest.com/docview/2734653812?pq-origsite=%requestingapplication%
PMID 36363468
PQID 2734653812
PQPubID 5046879
ParticipantIDs doaj_primary_oai_doaj_org_article_0ac541294c1d4d8491ae08d460d8123a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9698941
proquest_miscellaneous_2735868344
proquest_journals_2734653812
gale_infotracmisc_A744897520
gale_infotracacademiconefile_A744897520
pubmed_primary_36363468
crossref_citationtrail_10_3390_medicina58111511
crossref_primary_10_3390_medicina58111511
PublicationCentury 2000
PublicationDate 20221024
PublicationDateYYYYMMDD 2022-10-24
PublicationDate_xml – month: 10
  year: 2022
  text: 20221024
  day: 24
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Medicina (Kaunas, Lithuania)
PublicationTitleAlternate Medicina (Kaunas)
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Zota (ref_45) 2018; 2018
Maripov (ref_10) 2017; 2017
Cicco (ref_36) 2021; 82
Chetan (ref_58) 2021; 23
Montesi (ref_13) 2012; 142
Andrejic (ref_34) 2019; 9
Coniglio (ref_2) 2020; 1
ref_17
Singh (ref_18) 2019; 23
Maeder (ref_15) 2016; 460
Abe (ref_4) 2017; 24
Nagueh (ref_28) 2016; 29
Dong (ref_31) 2018; 41
Ferri (ref_39) 1995; 48
Bodez (ref_44) 2016; 109
Yaggi (ref_3) 2005; 353
Jun (ref_1) 2016; 139
ref_25
ref_21
Vural (ref_57) 2014; 69
Ventura (ref_40) 2016; 20
Colish (ref_47) 2012; 141
Andreieva (ref_32) 2018; 52
Bradley (ref_7) 2003; 107
ref_27
Lin (ref_24) 2019; 276
Arias (ref_9) 2005; 112
Egea (ref_42) 2008; 9
Ikejder (ref_43) 2020; 2020
Furlan (ref_46) 2022; 161
(ref_23) 2022; 26
Anton (ref_38) 2017; 2017
ref_35
Haruki (ref_53) 2010; 11
Schmitz (ref_20) 2005; 23
Tadic (ref_51) 2022; 24
Yu (ref_6) 2020; 45
Wan (ref_55) 2021; 10
Young (ref_5) 2002; 165
Papanikolaou (ref_8) 2019; 13
Daniels (ref_37) 2010; 160
Lang (ref_26) 2015; 28
Panjwani (ref_16) 2011; 92
Javaheri (ref_49) 2019; 201
McEvoy (ref_50) 2016; 375
Jankowich (ref_41) 2016; 1
Pusuroglu (ref_19) 2017; 75
Martone (ref_52) 2016; 33
Archontogeorgis (ref_14) 2014; 2014
Parasuraman (ref_30) 2016; 12
Kim (ref_54) 2019; 32
ref_48
Badano (ref_29) 2018; 19
Oudiz (ref_12) 2007; 28
Andreieva (ref_22) 2020; 56
Hansdottir (ref_11) 2013; 144
Ansari (ref_33) 2018; 38
Sacks (ref_56) 2018; 13
References_xml – volume: 112
  start-page: 375
  year: 2005
  ident: ref_9
  article-title: Obstructive sleep apnea syndrome affects left ventricular diastolic function: Effects of nasal continuous positive airway pressure in men
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.104.501841
– ident: ref_25
  doi: 10.3390/medicina58030350
– volume: 2014
  start-page: 930535
  year: 2014
  ident: ref_14
  article-title: Biomarkers to Improve Diagnosis and Monitoring of Obstructive Sleep Apnea Syndrome: Current Status and Future Perspectives
  publication-title: Pulm. Med.
  doi: 10.1155/2014/930535
– volume: 201
  start-page: 607
  year: 2019
  ident: ref_49
  article-title: CPAP Adherence for prevention of major adverse cerebrovascular and cardiovascular events in obstructive sleep apnea
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.201908-1593LE
– volume: 75
  start-page: 351
  year: 2017
  ident: ref_19
  article-title: Galectin-3 is associated with coronary plaque burden and obstructive sleep apnoea syndrome severity
  publication-title: Kardiol. Pol.
  doi: 10.5603/KP.a2016.0185
– ident: ref_27
  doi: 10.1161/JAHA.119.014609
– ident: ref_48
  doi: 10.1371/journal.pone.0062298
– volume: 2020
  start-page: 2587530
  year: 2020
  ident: ref_43
  article-title: Impact of Arterial Hypertension on Left Atrial Size and Function
  publication-title: Biomed Res. Int.
  doi: 10.1155/2020/2587530
– volume: 13
  start-page: 1753466619880076
  year: 2019
  ident: ref_8
  article-title: Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities
  publication-title: Ther. Adv. Respir. Dis.
  doi: 10.1177/1753466619880076
– volume: 141
  start-page: 674
  year: 2012
  ident: ref_47
  article-title: Obstructive sleep apnea: Effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI
  publication-title: Chest
  doi: 10.1378/chest.11-0615
– volume: 12
  start-page: 45
  year: 2016
  ident: ref_30
  article-title: Assessment of pulmonary artery pressure by echocardiography—A comprehensive review
  publication-title: IJC Heart Vasc.
  doi: 10.1016/j.ijcha.2016.05.011
– volume: 38
  start-page: 306
  year: 2018
  ident: ref_33
  article-title: Galectin-3 Reflects the Echocardiographic Grades of Left Ventricular Diastolic Dysfunction
  publication-title: Ann. Lab. Med.
  doi: 10.3343/alm.2018.38.4.306
– volume: 45
  start-page: 726
  year: 2020
  ident: ref_6
  article-title: Left ventricular remodeling and dysfunction in obstructive sleep apnea: Systematic review and meta-analysis
  publication-title: Herz
  doi: 10.1007/s00059-019-04850-w
– ident: ref_35
  doi: 10.1097/01.hjh.0000570772.89851.13
– volume: 13
  start-page: 612
  year: 2018
  ident: ref_56
  article-title: Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke
  publication-title: Int. J. Stroke
– volume: 28
  start-page: 1
  year: 2015
  ident: ref_26
  article-title: Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  publication-title: J. Am. Soc. Echocardiogr.
  doi: 10.1016/j.echo.2014.10.003
– volume: 82
  start-page: 117
  year: 2021
  ident: ref_36
  article-title: Galectin-3 and neutrophil-to-lymphocyte ratio are indicative of heart remodelling and disease severity in patients with obstructive sleep apnoea
  publication-title: Sleep Med.
  doi: 10.1016/j.sleep.2021.03.039
– volume: 23
  start-page: 213
  year: 2021
  ident: ref_58
  article-title: Understanding the role of echocardiography in patients with obstructive sleep apnea and right ventricular subclinical myocardial dysfunction Comparison with other conditions affecting RV deformation
  publication-title: Med. Ultrason.
– volume: 2017
  start-page: 2714095
  year: 2017
  ident: ref_38
  article-title: Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients
  publication-title: Dis. Markers
– volume: 10
  start-page: 2668
  year: 2021
  ident: ref_55
  article-title: Left atrial dysfunction in patients with obstructive sleep apnea: A combined assessment by speckle tracking and real-time three-dimensional echocardiography
  publication-title: Ann. Palliat. Med.
  doi: 10.21037/apm-20-1125
– volume: 41
  start-page: 599
  year: 2018
  ident: ref_31
  article-title: Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review)
  publication-title: Int. J. Mol. Med.
– volume: 2018
  start-page: 1206217
  year: 2018
  ident: ref_45
  article-title: Review of Echocardiographic Findings in Patients with Obstructive Sleep Apnea
  publication-title: Can. Respir. J.
– volume: 160
  start-page: 721
  year: 2010
  ident: ref_37
  article-title: Association of ST2 levels with cardiac structure and function and mortality in outpatients
  publication-title: Am. Heart J.
  doi: 10.1016/j.ahj.2010.06.033
– volume: 142
  start-page: 239
  year: 2012
  ident: ref_13
  article-title: Biomarkers of sleep apnea
  publication-title: Chest
  doi: 10.1378/chest.11-2322
– volume: 161
  start-page: 1370
  year: 2022
  ident: ref_46
  article-title: Effects of CPAP on Metabolic Syndrome in Patients With OSA: A Randomized Trial
  publication-title: Chest
  doi: 10.1016/j.chest.2021.12.669
– volume: 109
  start-page: 494
  year: 2016
  ident: ref_44
  article-title: Consequences of obstructive sleep apnoea syndrome on left ventricular geometry and diastolic function
  publication-title: Arch. Cardiovasc. Dis.
  doi: 10.1016/j.acvd.2016.02.011
– volume: 92
  start-page: 2
  year: 2011
  ident: ref_16
  article-title: Focus on molecules: Galectin-3
  publication-title: Exp. Eye Res.
  doi: 10.1016/j.exer.2010.11.009
– volume: 276
  start-page: 623
  year: 2019
  ident: ref_24
  article-title: Effect of continuous positive airway pressure on endothelin-1 in patients with obstructive sleep apnea: A meta-analysis
  publication-title: Eur. Arch. Otorhinolaryngol.
  doi: 10.1007/s00405-018-5225-8
– ident: ref_17
  doi: 10.3390/biom11081167
– volume: 24
  start-page: 795
  year: 2022
  ident: ref_51
  article-title: The impact of continuous positive airway pressure on cardiac mechanics: Findings from a meta-analysis of echocardiographic studies
  publication-title: J. Clin. Hypertens.
  doi: 10.1111/jch.14488
– volume: 26
  start-page: 231
  year: 2022
  ident: ref_23
  article-title: Endothelial dysfunction in obstructive sleep apnea patients
  publication-title: Sleep Breath.
  doi: 10.1007/s11325-021-02382-4
– volume: 56
  start-page: 4738
  year: 2020
  ident: ref_22
  article-title: Effects of CPAP and mandibular advancement devices on cardiac biomarkers in patients with obstructive sleep apnea
  publication-title: Eur. Respir. J.
– volume: 1
  start-page: 461
  year: 2016
  ident: ref_41
  article-title: Association of Elevated Plasma Endothelin-1 Levels With Pulmonary Hypertension, Mortality, and Heart Failure in African American Individuals: The Jackson Heart Study
  publication-title: JAMA Cardiol.
  doi: 10.1001/jamacardio.2016.0962
– volume: 29
  start-page: 277
  year: 2016
  ident: ref_28
  article-title: Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  publication-title: J. Am. Soc. Echocardiogr.
  doi: 10.1016/j.echo.2016.01.011
– volume: 32
  start-page: 826
  year: 2019
  ident: ref_54
  article-title: Continuous Positive Airway Pressure Therapy Restores Cardiac Mechanical Function in Patients with Severe Obstructive Sleep Apnea: A Randomized, Sham-Controlled Study
  publication-title: J. Am. Soc. Echocardiogr.
  doi: 10.1016/j.echo.2019.03.020
– volume: 11
  start-page: 352
  year: 2010
  ident: ref_53
  article-title: Continuous positive airway pressure ameliorates sleep-induced subclinical left ventricular systolic dysfunction: Demonstration by two-dimensional speckle-tracking echocardiography
  publication-title: Eur. J. Echocardiogr.
  doi: 10.1093/ejechocard/jep215
– volume: 1
  start-page: 45
  year: 2020
  ident: ref_2
  article-title: Sleep Breathing Disorders in Heart Failure
  publication-title: Heart Fail Clin.
  doi: 10.1016/j.hfc.2019.08.009
– volume: 353
  start-page: 2034
  year: 2005
  ident: ref_3
  article-title: Obstructive sleep apnea as a risk factor for stroke and death
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa043104
– volume: 144
  start-page: 638
  year: 2013
  ident: ref_11
  article-title: WHO’s in second?: A practical review of World Health Organization group 2 pulmonary hypertension
  publication-title: Chest
  doi: 10.1378/chest.12-2114
– volume: 139
  start-page: 12
  year: 2016
  ident: ref_1
  article-title: Sleep apnoea
  publication-title: Eur. Respir. Rev.
  doi: 10.1183/16000617.0077-2015
– volume: 33
  start-page: 1144
  year: 2016
  ident: ref_52
  article-title: Acute and Chronic Effects of Noninvasive Ventilation on Left and Right Myocardial Function in Patients with Obstructive Sleep Apnea Syndrome: A Speckle Tracking Echocardiographic Study
  publication-title: Echocardiography
  doi: 10.1111/echo.13225
– volume: 69
  start-page: 175
  year: 2014
  ident: ref_57
  article-title: Impact of continuous positive airway pressure therapy on left atrial function in patients with obstructive sleep apnoea: Assessment by conventional and two-dimensional speckle-tracking echocardiography
  publication-title: Acta Cardiol.
  doi: 10.1080/AC.69.2.3017299
– volume: 52
  start-page: PA4332
  year: 2018
  ident: ref_32
  article-title: The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea
  publication-title: Eur. Respir. J.
– volume: 24
  start-page: 884
  year: 2017
  ident: ref_4
  article-title: The Roles of Hypoxia Signaling in the Pathogenesis of Cardiovascular Diseases
  publication-title: J. Atheroscler. Thromb.
  doi: 10.5551/jat.RV17009
– volume: 23
  start-page: 479
  year: 2005
  ident: ref_20
  article-title: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
  publication-title: Immunity
  doi: 10.1016/j.immuni.2005.09.015
– volume: 165
  start-page: 1217
  year: 2002
  ident: ref_5
  article-title: Epidemiology of obstructive sleep apnea: A population health perspective
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.2109080
– volume: 375
  start-page: 919
  year: 2016
  ident: ref_50
  article-title: CPAP for prevention of cardiovascular events in obstructive sleep apnea
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1606599
– volume: 20
  start-page: 613
  year: 2016
  ident: ref_40
  article-title: Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea
  publication-title: Sleep Breath.
  doi: 10.1007/s11325-015-1260-5
– volume: 460
  start-page: 152
  year: 2016
  ident: ref_15
  article-title: Biomarkers of cardiovascular stress in obstructive sleep apnea
  publication-title: Clin. Chim. Acta.
  doi: 10.1016/j.cca.2016.06.046
– volume: 107
  start-page: 1671
  year: 2003
  ident: ref_7
  article-title: Sleep apnea and heart failure: Part I: Obstructive sleep apnea
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000061757.12581.15
– ident: ref_21
  doi: 10.1093/eurjcn/zvab060.126
– volume: 19
  start-page: 591
  year: 2018
  ident: ref_29
  article-title: Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: A consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging
  publication-title: Eur. Heart J. Cardiovasc. Imaging
  doi: 10.1093/ehjci/jey042
– volume: 28
  start-page: 233
  year: 2007
  ident: ref_12
  article-title: Pulmonary hypertension associated with left-sided heart disease
  publication-title: Clin. Chest Med.
  doi: 10.1016/j.ccm.2006.12.001
– volume: 48
  start-page: 519
  year: 1995
  ident: ref_39
  article-title: Circulating endothelin-1 concentrations in patients with chronic hypoxia
  publication-title: J. Clin. Pathol.
  doi: 10.1136/jcp.48.6.519
– volume: 9
  start-page: 660
  year: 2008
  ident: ref_42
  article-title: Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: A multicenter study
  publication-title: Sleep Med.
  doi: 10.1016/j.sleep.2007.06.018
– volume: 23
  start-page: 1107
  year: 2019
  ident: ref_18
  article-title: Sleep apnea and galectin-3: Possible sex-specific relationship
  publication-title: Sleep Breath.
  doi: 10.1007/s11325-019-01788-5
– volume: 9
  start-page: 13145
  year: 2019
  ident: ref_34
  article-title: Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-49511-4
– volume: 2017
  start-page: 1587865
  year: 2017
  ident: ref_10
  article-title: Right ventricular remodeling and dysfunction in obstructive sleep apnea: A systematic review of the literature and meta-analysis
  publication-title: Can. Respir. J.
  doi: 10.1155/2017/1587865
SSID ssj0032572
Score 2.3142169
Snippet Background: Cardiovascular remodeling is essential in patients with obstructive sleep apnea (OSA), and continuous positive airway pressure (CPAP) therapy could...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1511
SubjectTerms Airway management
Analysis
Biological markers
Biomarkers
Blood pressure
Cardiovascular disease
Cardiovascular system
Care and treatment
Clinical trials
Continuous positive airway pressure
Continuous Positive Airway Pressure - methods
Diagnosis
endothelin-1
Galectin 3
Heart
Humans
Hypoxia
Measurement
Methods
Mortality
Obesity - complications
obstructive sleep apnea
Patient compliance
Patient outcomes
Polysomnography
Pulmonary arteries
Pulmonary hypertension
Serum
Sleep apnea
Sleep apnea syndromes
Sleep Apnea, Obstructive - complications
Sleep Apnea, Obstructive - therapy
sST2
two-dimensional speckle-tracking echocardiography
Ventricular Dysfunction, Left
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9QwFA-yiHgRv62uEkEQYcukbZImxxlx3IOuA64wt5JJXrGw0xnazsr-Q_6dvjSdYaqgF-mteYEm77t5-T1C3igBucI0I5ZZzmKerli8gqxEvdJ5atPSSsv7ZhP5xYVaLvXiqNWXrwkL8MBh4ybMWMHRKXGbOO4U14kBphyXzKFvyvrQCKOefTIVbHCGghjOOdHKSMmW4YAywwR_MpxZG6FQzUWSjBxSj9v_p3U-ck_j0skjXzS_T-4NQSSdho9_QG5B_ZDc-Twckz8iP8OdgZZWNf0EZUfPUZ47-hE2a-iamzM6R2_mOXJGTe3ozBevU7QauzWdVZu1r9hp-smLgLraUv-7ln5ZDWiz10C_XgFs6XRbg6F9n3F6uS9ZD8Qe9qqqd5tdSxd9YRhOmlbND3NDw5XEBh6Tb_MPl-_P46EhQ2yFyLtYrDBBdMqY1JYcPICBTleZApc4wUA7XWI8BWA47r-WGpiwqpSaG6VLmTGXPSEn9aaGZ4Qa5rR0aIo5ppgSQJc5BqI2MVlubAJpRCZ7rhR2QCv3TTOuCsxaPB-L3_kYkXeHGduA1PEX2pln9IHOY2z3L1DyikHyin9JXkTeejEpvCXAT7NmuNCAC_SYWsU0x9RX5yJlETkdUaIG2_HwXtCKwYK0hYcdkuiNEtyK14dhP9NXxdWA7PM0QknfKSUiT4NcHpaUSXy4VBHJRxI7WvN4pK6-9_ji2jcV5cnz_7FJL8jd1F8YQT1M-Sk5QTGFl-S2ve6qtnnVK-0v-lNGuQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Changes in Left Heart Geometry, Function, and Blood Serum Biomarkers in Patients with Obstructive Sleep Apnea after Treatment with Continuous Positive Airway Pressure
URI https://www.ncbi.nlm.nih.gov/pubmed/36363468
https://www.proquest.com/docview/2734653812
https://www.proquest.com/docview/2735868344
https://pubmed.ncbi.nlm.nih.gov/PMC9698941
https://doaj.org/article/0ac541294c1d4d8491ae08d460d8123a
Volume 58
WOSCitedRecordID wos000881113900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1648-9144
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032572
  issn: 1648-9144
  databaseCode: DOA
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 1648-9144
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032572
  issn: 1648-9144
  databaseCode: 7X7
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1648-9144
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032572
  issn: 1648-9144
  databaseCode: BENPR
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1648-9144
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0032572
  issn: 1648-9144
  databaseCode: PIMPY
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bi9QwFA7urIgv3ler6xBBEGHL9JLm8iQzsuMK7lh0hfGpZJJUCzvt2M6s7B_yd3rSZsatwr5IYaBNAsnkOyfnJCffQeglTwzj4Gb4NGaBT6JF4C9MnINcCRapKFdUkTbZBJvN-HwuUrfh1riwyq1ObBW1rpTdIx9ZGhYK0hlGb1Y_fJs1yp6uuhQae2jfMpWRAdqfHM_ST1tdHAMgu_NO0DaUBvPuoDIGR3_kzq5lwkHckzDsLUwtf_-_WvrKMtUPobyyJk3v_u9o7qE7zhrF4w4-99ENUz5At07deftD9Ku7fNDgosQfTL7GJyAYa_zOVEuzri-P8BSWRTu1R1iWGk9sFDwG9bNZ4klRLW3oT902Tjv61gbbfV_8ceFoay8M_nxuzAqPV6WRuE1Yjs-2se9dZcufVZSbatPgtI0wg0bjov4pL3F3t7E2j9CX6fHZ2xPfZXbwVZKwtZ8swNPUXMpI5cRYJgQRLWJudKiTwAgtcjDMjJEEJlBQYYJE8ZwKIrnIaRzo-AANyqo0TxCWgRZUg04n4KtSY0TOwKJVoYyZVKGJPDTaTmumHO25zb5xnoH7Y4GQ_Q0ED73etVh1lB_X1J1YpOzqWbLu9kNVf8uc7GeBVAkBuwp6pYnmRITSBFwTCn8BGA7SQ68szjKrUqBrSrqbETBAS86VjRn40IIlUeChw15NUAWqX7xFW-ZUUZP9gZqHXuyKbUsbXlcamD5bJ-HUplzx0OMO2LshxRQeQrmHWA_yvTH3S8rie0tULmx2UhI-vb5bz9DtyN4pARGNyCEaAADNc3RTXayLph6iPTZn7S8fOukethsn8Ja-P02__gb0bVtc
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lj9MwELaWLgIuvB-BBYwEQkgbNQ_HsQ8ItUBptW2pRJHKKbjOBCptk9LHrvqHOPIbGedRNiDtbQ-ot9iubOebb2bi8Qwhz0UAoUA3w-Z-6NjMmzr2FPwE5UqGnvYSzTXLi02Ew6GYTORoj_yq7sKYsMqKE3OijjNtvpE3TRoWjtLpem8WP2xTNcqcrlYlNApYHMH2FF221eveO3y_Lzyv8378tmuXVQVsHQTh2g6m6OXEQilPJwzMLXzpTX0BsRsHDshYJmgUACjmo2fAJTiBFgmXTAmZcN-JffzfS2SfIdhFg-yPeoPRl4r7cUhYnK8iu3HuTIqDUd-XTrM8K1eBQHoJXLemCPN6Af9qhTNqsR6yeUYHdm78b7t3k1wvrW3aKsTjFtmD9Da5MijjCe6Qn8XlihWdpbQPyZp2cY5r-gGyOayX20PaQbVvoHtIVRrTtonyp0ivmzltz7K5CW1a5oNHRXraFTXftenHaZmW9wTop2OABW0tUlA0L8hOx1Vsf9HZ5AebpZtss6KjPIIOB7Vmy1O1pcXdzSXcJZ8vZJfukUaapfCAUOXEkseosxj64hxAJiFa7NpVfqi0C55FmhWMIl2mdTfVRY4jdO8M8KK_gWeRV7sRiyKlyTl92waZu34mGXn-IFt-i0puixylA4Z2I84qZrFg0lXgiJhx3AI0jJRFXhpcR4YycWpalTc_cIEm-VjUChkTMgw8xyIHtZ5IdbreXKE7Kql2Ff2BtkWe7ZrNSBM-mAK-PtMnENyUlLHI_UKQdkvyOf4YFxYJayJWW3O9JZ19zxOxS1N9lbkPz5_WU3K1Ox70o35vePSIXPPQKi4iSA9IA8EIj8llfbKerZZPSjah5OtFi-Bvs_Ozjw
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VFlVceD8MBRYJhJBqxY_1eveAUEIJjdqGSLRSOJnNegyWGjvESav8IX4Ev45ZP0INUm89oNy8s9HueuabGe88CHkpAggFuhk290PHZt7EsSfgJyhXMvS0l2iuWdlsIhwOxXgsRxvkV5MLY8IqG0wsgTrOtflG3jFlWDhKp-t1kjosYrTXfzf7YZsOUuamtWmnUbHIAazO0X0r3g728F2_8rz-h-P3-3bdYcDWQRAu7GCCHk8slPJ0wsBk5Etv4guI3ThwQMYyQQMBQDEfvQQuwQm0SLhkSsiE-07s4_9eI1tokjOUsa3R4Gj0pdEDOCWs7loR6Th3xtUlqe9Lp1Pfm6tAINQErttSimXvgH81xAUV2Q7fvKAP-7f-55O8TW7WVjjtVmJzh2xAdpdsH9VxBvfIzyrpoqBpRg8hWdB9XOOCfoR8Cov5apf20RwwLL1LVRbTnon-pwi7yyntpfnUhDzNy8mjqmxtQc33bvppUpfrPQP6-RRgRruzDBQtG7XT4ybmvyI2dcPSbJkvCzoqI-twUjedn6sVrXI653CfnFzJKT0gm1mewSNClRNLHqMuY-ijcwCZhGjJa1f5odIueBbpNCwV6brcu-k6chqh22eYMPqbCS3yZj1jVpU6uYS2Z7h0TWeKlJcP8vm3qMa8yFE6YGhP4qpiFgsmXQWOiBnHI0CDSVnkteHxyEApLk2rOiMEN2iKkkXdkDEhw8BzLLLTokQI1O3hhtOjGoKL6A-bW-TFetjMNGGFGeDrMzSB4KbVjEUeVkK13pLP8ce4sEjYErfWntsjWfq9LNAuTVdW5j6-fFnPyTbKXXQ4GB48ITc8k1aDSOGxHbKJvAhPyXV9tkiL-bMaWCj5etUS-Btat7xL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+Left+Heart+Geometry%2C+Function%2C+and+Blood+Serum+Biomarkers+in+Patients+with+Obstructive+Sleep+Apnea+after+Treatment+with+Continuous+Positive+Airway+Pressure&rft.jtitle=Medicina+%28Kaunas%2C+Lithuania%29&rft.au=Kondratavi%C4%8Dien%C4%97%2C+Laima&rft.au=Tamul%C4%97nait%C4%97%2C+Egl%C4%97&rft.au=Vasyl%C4%97%2C+Egl%C4%97&rft.au=Janu%C5%A1kevi%C4%8Dius%2C+Andrius&rft.date=2022-10-24&rft.pub=MDPI+AG&rft.issn=1010-660X&rft.eissn=1648-9144&rft.volume=58&rft.issue=11&rft.spage=1511&rft_id=info:doi/10.3390%2Fmedicina58111511&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1648-9144&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1648-9144&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1648-9144&client=summon